Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability Indices

Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability Indices

• The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy
• Roche performed particularly well in innovation management, access to healthcare, greenhouse gas emissions, water management, resource efficiency and circularity, labour practice indicators and human rights
• This marks the 15th consecutive year that Roche has maintained its leading ranking
  
  

Basel, 15 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). Roche ranked third, Chugai Pharmaceuticals, a member of the Roche Group, ranked second.

“We are extremely proud that our deep commitment to sustainability in all our business practices has been recognised again,” said Roche CEO Thomas Schinecker. “It is a fantastic achievement that Chugai and Roche came in second and third, respectively. This double recognition reflects the innovation the Roche Group brings to society, and our commitment to continually embed sustainable practices in our strategy and culture.”

For the past 15 consecutive years, Roche has maintained its leading ranking, which is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios.

Sustainability at Roche
For over 125 years, sustainability has been an integral part of Roche’s business. Roche follows a holistic approach to sustainability and integrates the three dimensions of sustainability:

• Society: how we contribute to a better tomorrow for all
• Environment: how we minimise our impact on nature
• Economy: how we invest in medical advances, create jobs and ensure livelihoods
  
  

Roche makes its biggest contribution to society by improving healthcare provision. It does so by developing innovative treatments across major disease areas and medical assays, digital solutions and services helping people live healthier lives.

Roche is aware that this cannot be done alone. The key to creating sustainable value and growth lies in partnering with stakeholders and engaging in open, constructive dialogue. By doing so, Roche generates value for society and achieves sustainable economic growth for the company. We apply this approach to reducing our overall environmental impacts across our business, well beyond decarbonisation, setting long-term goals, measuring our environmental impact and having an end-to-end focus on our products.